Axo Longevity offers membership-based biomarker testing and digital health plans for preventive wellness and longevity optimization.
Axo Longevity has raised $5.0M in total funding. The most recent round was Seed. The last funding was announced in September 2026.
Axo Longevity's investors include LifeX Ventures, Everywhere Ventures, Life Extension Ventures, Izou Partners, The 51 Ventures.
Axo Longevity is headquartered in London, United Kingdom.
Axo Longevity offers membership-based biomarker testing and digital health plans for preventive wellness and longevity optimization.
Axo Longevity is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Axo Longevity — Funding & Investors." VCBacked, September 15, 2026, https://www.vcbacked.co/company/axo-longevity. Accessed October 1, 2026.
VCBacked. (2026). Axo Longevity — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/axo-longevity
{{cite web |title=Axo Longevity — Funding & Investors |url=https://www.vcbacked.co/company/axo-longevity |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated